APTAMIC: New aptamer conjugates mimicking monoclonal antibody activity
- Share
- Share on Facebook
- Share on X
- Share on LinkedIn

This project aims at developing antibody mimics targeting a B cell receptor – CD20. This protein is an important immune target for the treatment of many diseases (lymphomas, auto-immune diseases, …).
I am from Lyon, France, where I started my studies before moving to Switzerland for a MSc degree in the École Polytechnique Fédérale de Lausanne (EPFL). I then pursued my PhD at the University of Geneva, working on dynamic covalent chemistry for the cellular uptake of biomolecules. Before coming ot Grenoble, I spent two years as a postdoctoral fellow in McGill University (Montréal, Canada).
I have always been interested in understanding how biological processes worked and am fascinated by all the ways chemistry has to influence these processes. For this, I am happy to be part of the Arcane Labex and its goals to bridge the gap between chemistry and biology.
The thing that I am most proud of in my research is the success of the several undergraduate and PhD students I had the chance to train in Montréal. Seeing them grow as scientists, be more assertive of their expertise and succeed in their careers is what makes me the happiest in research.
Following this contract, I am applying to the CNRS as a Chargé de Recherche to start building my own research.
- Share
- Share on Facebook
- Share on X
- Share on LinkedIn